228 related articles for article (PubMed ID: 24188700)
1. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
Brady M; Manning J
Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
[TBL] [Abstract][Full Text] [Related]
2. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing multipurpose prevention technology development and investments using a target product profile.
Romano J; Manning J; Hemmerling A; McGrory E; Holt BY
Antiviral Res; 2013 Dec; 100 Suppl():S32-8. PubMed ID: 24188707
[TBL] [Abstract][Full Text] [Related]
4. Multipurpose prevention technologies: products in development.
Friend DR; Clark JT; Kiser PF; Clark MR
Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
[TBL] [Abstract][Full Text] [Related]
5. Making the case for multipurpose prevention technologies: the socio-epidemiological rationale.
Boonstra H; Barot S; Lusti-Narasimhan M
BJOG; 2014 Oct; 121 Suppl 5():23-6. PubMed ID: 25335837
[TBL] [Abstract][Full Text] [Related]
6. Designing a multipurpose technology for acceptability and adherence.
Tolley EE; Morrow KM; Owen DH
Antiviral Res; 2013 Dec; 100 Suppl(0):S54-9. PubMed ID: 24188706
[TBL] [Abstract][Full Text] [Related]
7. Aligning product development and user perspectives: social-behavioural dimensions of multipurpose prevention technologies.
Brady M; Tolley E
BJOG; 2014 Oct; 121 Suppl 5():70-8. PubMed ID: 25335843
[TBL] [Abstract][Full Text] [Related]
8. Beyond HIV microbicides: multipurpose prevention technology products.
Malcolm RK; Boyd P; McCoy CF; Murphy DJ
BJOG; 2014 Oct; 121 Suppl 5():62-9. PubMed ID: 25335842
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
[TBL] [Abstract][Full Text] [Related]
10. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
[TBL] [Abstract][Full Text] [Related]
11. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa.
Minnis AM; Krogstad E; Shapley-Quinn MK; Agot K; Ahmed K; Danielle Wagner L; van der Straten A;
Sex Reprod Health Matters; 2021 Dec; 29(1):1927477. PubMed ID: 34224341
[TBL] [Abstract][Full Text] [Related]
12. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
Friend DR; Doncel GF
Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.
Quaife M; Terris-Prestholt F; Eakle R; Cabrera Escobar MA; Kilbourne-Brook M; Mvundura M; Meyer-Rath G; Delany-Moretlwe S; Vickerman P
J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537654
[TBL] [Abstract][Full Text] [Related]
14. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
[TBL] [Abstract][Full Text] [Related]
15. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
[TBL] [Abstract][Full Text] [Related]
16. Lessons learnt from sexual and reproductive health and HIV linkages for multipurpose prevention technology service delivery.
Lusti-Narasimhan M; Collins L; Hopkins J
BJOG; 2014 Oct; 121 Suppl 5():87-91. PubMed ID: 25335845
[TBL] [Abstract][Full Text] [Related]
17. Vaginal multipurpose prevention technologies: promising approaches for enhancing women's sexual and reproductive health.
Fernandes T; Baxi K; Sawarkar S; Sarmento B; das Neves J
Expert Opin Drug Deliv; 2020 Mar; 17(3):379-393. PubMed ID: 32036727
[No Abstract] [Full Text] [Related]
18. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on sexual and reproductive health self-care among women, healthcare providers, and other key informants: a mixed-methods study in South Africa and Zambia.
Cartwright AF; Velarde M; Beksinska M; Smit J; Kasaro M; Tang JH; Milford C; Maphumulo V; Chinyama M; Chabu E; Mudenda M; Wong C; Fawzy M; Callahan R
Reprod Health; 2023 Apr; 20(1):65. PubMed ID: 37118835
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.
Bershteyn A; Resar D; Kim HY; Platais I; Mullick S
Front Reprod Health; 2023; 5():1169110. PubMed ID: 37325241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
